AXSM - Axsome Therapeutics GAAP EPS of -$1.44 misses by $0.21 revenue of $75M beats by $2.15M
2024-05-06 07:01:57 ET
More on Axsome Therapeutics
- Axsome: Unpacking Auvelity's First-Year Market Dynamics And Economic Challenges
- Axsome Therapeutics, Inc. (AXSM) Q4 2023 Earnings Call Transcript
- Axsome Therapeutics Q1 2024 Earnings Preview
- Axsome Therapeutics stock rises on upgrade to Overweight at Morgan Stanley
- Seeking Alpha’s Quant Rating on Axsome Therapeutics